Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 3.3T | 3.6T | 3.2T | 3.1T |
Cost of revenue | 3.0T | 3.2T | 2.9T | 2.8T |
Gross profit | 335.3B | 376.0B | 307.7B | 300.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 208.0B | 194.6B | 207.5B | 184.2B |
Other operating expenses | — | — | — | — |
Operating income | 127.3B | 181.5B | 100.1B | 116.5B |
Non operating interest income | ||||
Income | 13.8B | 16.3B | 18.4B | 15.8B |
Expense | 46.2B | 41.4B | 41.9B | 38.6B |
Other income expense | — | — | — | — |
Pretax income | 368.9B | 339.7B | 282.1B | 311.8B |
Tax provision | 31.6B | 65.7B | 71.4B | 53.2B |
Net income | 337.3B | 273.9B | 210.6B | 258.7B |
Basic EPS | — | 179.6 | 134.9 | 166.4 |
Diluted EPS | — | 179.5 | 134.8 | 166.4 |
Basic average shares | — | 1.5B | 1.5B | 1.5B |
Diluted average shares | — | 1.5B | 1.5B | 1.5B |
EBITDA | 505.0B | 438.4B | 300.4B | 373.1B |
Net income from continuing op. | 337.3B | 273.9B | 210.6B | 258.7B |
Minority interests | 7M | -3.8B | -7.2B | -5.8B |
Preferred stock dividends | 0 | 0 | 0 | 0 |